Skip to content
Screener

Alumis Inc. ALMS Operating margin

Operating margin at other companies

Amgen logo
AmgenAMGN
30%+6.5pp
Immunome logo
ImmunomeIMNM
-5,947.9%-12,002pp
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-15,536.1%-17,275pp
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
15.4%—
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
-1,050.2%+266pp
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
20.7%+9.2pp

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.54B+686%
Enterprise value$3.52B+940%
P/S421.8×—

Profitability

See full
Net margin-2,825.7%—
FCF margin-4,487.4%—

Returns & leverage

See full
Return on equity-64.6%—
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Calculated from Alumis Inc.’s reported figures.

operating income/total revenue=-5,364%

Based on trailing twelve months.

The source filing: Alumis Inc.’s 10-Q, filed May 14, 2026. Open the filing →

Filed
May 14, 2026, 4:16 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001847367-26-000010

FAQ

What is Alumis Inc.'s operating margin?
Alumis Inc. (ALMS) reported operating margin of -5,364% in Q1 2026.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.

Ask your AI about Alumis Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude